Gefitstar 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Gefitstar 250 mg Tablet

Gefitstar 250 mg Tablet

Gefitstar 250 mg Tablet contains gefitinib 250 mg, a tyrosine kinase inhibitor used in the treatment of certain types of lung cancer. It is mainly prescribed for non-small-cell lung cancer with specific EGFR mutations. The tablet is taken orally as directed by an oncologist.

BUY NOW

Category

Gefitinib works by blocking epidermal growth factor receptor (EGFR) signaling, which can help slow the growth and spread of certain cancer cells. It is generally used when the tumor has an appropriate EGFR mutation confirmed through diagnostic testing. Treatment may require monitoring for diarrhea, skin reactions, liver function abnormalities, and other adverse effects. The dose and duration are determined by the treating oncologist according to the patient’s cancer characteristics and response to treatment.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Lupin Ltd

Product Also Known As

Gefitstar 250 mg Tablet, Gefitstar 250mg Tablet, Gefitstar 250 Tablet, Gefitinib 250 mg Tablet, Gefitinib 250mg Tablet, Gefitinib Oral Tablet, Gefitinib Lung Cancer Tablet